HRT Financial’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-83,199
| Closed | -$44K | – | 2221 |
|
|
2024
Q4 | $44K | Buy |
+83,199
| New | +$44K | ﹤0.01% | 1910 |
|
|
2024
Q1 | – | Sell |
-59,906
| Closed | -$47K | – | 2092 |
|
|
2023
Q4 | $47K | Buy |
+59,906
| New | +$47K | ﹤0.01% | 1796 |
|
|
2023
Q2 | – | Sell |
-18,047
| Closed | -$19K | – | 2170 |
|
|
2023
Q1 | $19K | Buy |
+18,047
| New | +$19K | ﹤0.01% | 2003 |
|
|
2022
Q3 | – | Sell |
-21,091
| Closed | -$35K | – | 2522 |
|
|
2022
Q2 | $35K | Buy |
+21,091
| New | +$35K | ﹤0.01% | 2466 |
|
|
2021
Q3 | – | Sell |
-42,621
| Closed | -$181K | – | 2946 |
|
|
2021
Q2 | $181K | Buy |
+42,621
| New | +$181K | ﹤0.01% | 2324 |
|
|
2020
Q1 | – | Sell |
-44,245
| Closed | -$53K | – | 594 |
|
|
2019
Q4 | $53K | Buy |
+44,245
| New | +$53K | ﹤0.01% | 1016 |
|